| |
| |
|
| Insider
Information: |
Schwab Gisela Md |
| Relationship: |
Pres, Prod Dev & Med A... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
689,078 |
|
|
Indirect Shares
|
14,880 |
|
|
| Direct
Value |
$14,877,194 |
|
|
|
Indirect Value
|
$321,259 |
|
|
| Total
Shares |
703,958 |
|
|
| Total
Value |
$15,198,453 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -38.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Pres, Prod Dev & Med A... |
2021-07-26 |
689,078 |
2021-07-26 |
14,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-07-26 |
4 |
OE |
$4.20 |
$168,000 |
D/D |
40,000 |
689,078 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-07-21 |
4 |
OE |
$4.20 |
$147,000 |
D/D |
35,000 |
649,078 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-05-13 |
4 |
AS |
$25.38 |
$2,538,000 |
D/D |
(100,000) |
614,078 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-05-13 |
4 |
OE |
$1.90 |
$190,000 |
D/D |
100,000 |
714,078 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-04-26 |
4 |
AS |
$25.00 |
$1,250,000 |
D/D |
(50,000) |
613,482 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-04-26 |
4 |
OE |
$1.70 |
$85,000 |
D/D |
50,000 |
663,482 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-04-01 |
4 |
AS |
$23.00 |
$1,150,000 |
D/D |
(50,000) |
613,482 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-04-01 |
4 |
OE |
$1.70 |
$85,000 |
D/D |
50,000 |
663,482 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
72,885 |
613,482 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-18 |
4 |
S |
$22.35 |
$1,117,500 |
D/D |
(50,000) |
540,597 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-18 |
4 |
OE |
$1.70 |
$85,000 |
D/D |
50,000 |
590,597 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-17 |
4 |
OE |
$1.70 |
$85,000 |
D/D |
50,000 |
590,597 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-17 |
4 |
S |
$22.50 |
$1,125,000 |
D/D |
(50,000) |
540,597 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-15 |
4 |
D |
$21.91 |
$62,619 |
D/D |
(2,858) |
540,597 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-03 |
4 |
D |
$22.56 |
$337,994 |
D/D |
(14,982) |
543,455 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
81,038 |
558,437 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-11-15 |
4 |
D |
$20.16 |
$301,452 |
D/D |
(14,953) |
477,399 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
213,879 |
547,070 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-10-22 |
4 |
D |
$21.79 |
$1,203,571 |
D/D |
(55,235) |
491,835 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-09-02 |
4 |
D |
$21.58 |
$54,317 |
D/D |
(2,517) |
333,191 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,745 |
335,708 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-06-04 |
4 |
AS |
$22.96 |
$2,296,000 |
D/D |
(100,000) |
325,963 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-06-04 |
4 |
OE |
$1.70 |
$170,000 |
D/D |
100,000 |
425,963 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-04-23 |
4 |
OE |
$1.70 |
$170,000 |
D/D |
100,000 |
425,122 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-04-23 |
4 |
AS |
$26.00 |
$2,600,000 |
D/D |
(100,000) |
325,122 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
